Release No 4/2010 Revised Financial Calendar 2010 Changed date for Release of 2009 Financial Results Copenhagen and Oslo, March 26th, 2010 Affitech A/S has changed the date for the release of its full year financial results and Annual Report from March 26th to March 31st, 2010. Affitech A/S's updated financial calendar is as follows: March 31st 2010: Financial Results for 2009 April 29th 2010: Annual General Meeting May 19th 2010: Interim financial report for 1st quarter 2010 August 26th 2010: Interim financial report for 2nd quarter 2010 November 18th 2010: Interim financial report for 3rd quarter 2010 -------------------------------------------------------------------------------- | For more information please contact: | -------------------------------------------------------------------------------- | | | Affitech A/S: | | | | Randi Krogsgaard | | Tel # +45 2048 8384 | -------------------------------------------------------------------------------- About Affitech Affitech AS is a publically traded (NASDAQ OMX Copenhagen) therapeutic antibody company headquartered in Copenhagen, Denmark with R&D facilities in Oslo, Norway. The company utilizes a range of proprietary antibody technologies for the discovery of therapeutic antibodies for application in oncology, inflammation and other disease areas. CBAS™ (Cell Based Antibody Selection) is Affitech A/Ss premier technology platform for the isolation of lead antibodies to cell surface targets. Several of the Company's proprietary drug candidates were generated by CBAS™. Further information is available at www.affitech.com.